Literature DB >> 3359594

Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ.

M R Franz1, A Costard.   

Abstract

To determine the normal relationship in vivo between action potential duration (APD) and effective refractory period (ERP) over a large range of steady-state cycle lengths (CLs) and to determine how a sodium channel-blocking agent, quinidine, affects this relationship, we developed a new contact electrode technique for simultaneous measurements of monophasic action potentials and refractoriness at a single site in the beating heart in situ. Recordings were made from left ventricular epicardium in open-chest dogs during steady-state pacing at CLs from 220 to 600 msec both before and after therapeutic intravenous administration of quinidine. During baseline both APD at 90% repolarization (APD90) and ERP were linearly correlated to CL with nearly identical slopes: y = 0.24x CL + 83.0 (r = 1.0; p less than .0001) for APD90 and y = 0.22x CL + 82.3 (r = 1.0; p less than .0001) for ERP. Expressed in percent repolarization, ERP coincided with a repolarization level of 79% to 83%, with no appreciable influence of CL on this relationship. Quinidine increased APD90 by a small but significant amount (8 to 12 msec), which was independent of CL. In contrast, the effect on ERP of quinidine exhibited marked frequency dependence (p less than .0002), producing progressively greater ERP increase at shorter CLs, as compared with both baseline ERP and concomitant APD90. The duration by which ERP exceeded APD90 reached 44 +/- 14 msec at a CL of 220 msec.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3359594     DOI: 10.1161/01.cir.77.5.1177

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Simultaneous assessment of the hemodynamic, cardiomechanical, and electrophysiological effects of terfenadine on the in vivo canine model.

Authors:  T Usui; A Sugiyama; Y Ishida; Y Satoh; Y Sasaki; K Hashimoto
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

2.  Failure to reproduce the in vitro cardiac electrophysiological effects of naloxone in humans.

Authors:  K G Oldroyd; A C Rankin; C E Gray; K Harvey; W Borland; A P Rae; S M Cobbe
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

3.  Direct quantification of apparent binding indices from quinidine-induced in vivo conduction delay in canine myocardium.

Authors:  F N Haugland; S B Johnson; D L Packer
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

4.  Dronedarone attenuates the duration of atrial fibrillation in a dog model of sustained atrial fibrillation.

Authors:  Nakkawee Saengklub; Vudhiporn Limprasutr; Suwanakiet Sawangkoon; Robert L Hamlin; Anusak Kijtawornrat
Journal:  Exp Anim       Date:  2017-04-04

5.  Refractory dispersion promotes conduction disturbance and arrhythmias in a Scn5a (+/-) mouse model.

Authors:  Claire A Martin; Andrew A Grace; Christopher L-H Huang
Journal:  Pflugers Arch       Date:  2011-07-21       Impact factor: 3.657

6.  Atrial arrhythmogenesis in wild-type and Scn5a+/delta murine hearts modelling LQT3 syndrome.

Authors:  Yana Dautova; Yanmin Zhang; Ian Sabir; Andrew A Grace; Christopher L-H Huang
Journal:  Pflugers Arch       Date:  2009-01-28       Impact factor: 3.657

7.  The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillation.

Authors:  John Ford; James Milnes; Said El Haou; Erich Wettwer; Simone Loose; Klaus Matschke; Benoit Tyl; Patrick Round; Ursula Ravens
Journal:  Heart Rhythm       Date:  2015-10-13       Impact factor: 6.343

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.